Xiaorong Li
Impact in
- Ophthalmology top 0.2%
- Retinal Diseases and Treatments
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Ophthalmology 161
- Retinal Diseases and Treatments 102
- Glaucoma and retinal disorders 56
- Ocular Diseases and Behçet’s Syndrome 32
-
- Retinal Imaging and Analysis 41
- Retinal and Macular Surgery 33
Xiaorong Li
506 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Ophthalmology 1.8k
- Cancer Research 2.1k
- Molecular Biology 5.3k
- Radiology, Nuclear Medicine and Imaging 1.7k
- Genetics 689
Countries citing papers authored by Xiaorong Li
This map shows the geographic impact of Xiaorong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Li more than expected).
Fields of papers citing papers by Xiaorong Li
This network shows the impact of papers produced by Xiaorong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Li. The network helps show where Xiaorong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaorong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 26 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 19 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 54 | |
| 17 | 2022 | 3 | |
| 18 | 2017 | 4 | |
| 19 | 2015 | 122 | |
| 20 | [Comparative study of eukaryotic cell expression of wild-type and Pro370Leu mutation type myocilin gene]. | 2006 | 1 |
About Xiaorong Li
Xiaorong Li is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Molecular Biology and Neurology, having authored 550 papers that have together received 10.8k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (102 papers), Glaucoma and retinal disorders (56 papers), Retinal Imaging and Analysis (41 papers), Retinal and Macular Surgery (33 papers), Cancer-related molecular mechanisms research (33 papers), Ocular Diseases and Behçet’s Syndrome (32 papers), Retinal Development and Disorders (29 papers) and MicroRNA in disease regulation (27 papers). The work is most often cited by research in Ophthalmology (1.8k citations), Cancer Research (2.1k citations), Molecular Biology (5.3k citations), Radiology, Nuclear Medicine and Imaging (1.7k citations) and Genetics (689 citations). Xiaorong Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiaomin Zhang, Bo Yu, Changwei Lin, Yan Shao, Gui Hu, Xinjun Ren, Hui Shao, Shaochong Bu, Lijie Dong and Ming Xue. Their work appears in journals such as BMC Ophthalmology, Experimental Eye Research, PLoS ONE, International Journal of Molecular Sciences and Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.